Pancreatic Cancer Research

ResearcherCalifornia Institute of TechnologyActive in the last 2 years

Xiao Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0063-3468; OpenAlex author ID A5103067281. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. Co-author DOI 10.1021/acsnano.4c14102↗
  2. Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures. Co-author DOI 10.3389/fmolb.2021.645024↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lijia Luo · 1 shared paper, 2025 · strength 0.33
  2. Xiang Wang · 1 shared paper, 2025 · strength 0.33
  3. André E. Nel · 1 shared paper, 2025 · strength 0.33
  4. Shengyang Chen · 1 shared paper, 2021 · strength 0.14
  5. Congjun Zhang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.